Evidence map›Paper›PMID 32163505›Full record

ArticlePloS one2020

High expression of Helicobacter pylori VapD in both the intracellular environment and biopsies from gastric patients with severity.

Rosario Morales-Espinosa, Gabriela Delgado, Luis-Roberto Serrano, Elizabeth Castillo, Carlos A Santiago, Rigoberto Hernández-Castro, Alberto Gonzalez-Pedraza, Jose L Mendez, Luis F Mundo-Gallardo, Joaquín Manzo-Merino and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 21 citations in OpenAlex.

  1. Internalization ofAnnals of medicine · 2026
    Review
  2. The role of toxin-antitoxin systems inJournal of bacteriology · 2026
    Review
  3. Expression of the VapD protein byMicrobiology (Reading, England) · 2026
    Article
  4. Article
  5. Article
  6. CoccoidVirulence · 2025
    Review
  7. Microorganisms · 2025
    Article
  8. Pathotyping and molecular serotyping of clinical isolates of Glaesserella parasuis in Taiwan.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Study ofCancers · 2023
    Article
  13. Article
  14. World journal of gastroenterology · 2021
    Article
  15. Article
  16. Defining theFrontiers in microbiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Rosario Morales-EspinosaFacultad de Medicina, Departamento de Microbiología y Parasitología, Universidad Nacional Autónoma de México, Mexico City, Mexico.ORCID 0000-0003-2110-4397
Gabriela DelgadoFacultad de Medicina, Departamento de Microbiología y Parasitología, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Luis-Roberto SerranoFacultad de Medicina, Departamento de Microbiología y Parasitología, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Elizabeth CastilloFacultad de Medicina, Departamento de Microbiología y Parasitología, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Carlos A SantiagoFacultad de Medicina, Departamento de Microbiología y Parasitología, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Rigoberto Hernández-CastroDepartamento de Ecología de Agentes Patógenos, Hospital Manuel Gea González, Mexico City, Mexico.
Alberto Gonzalez-PedrazaFacultad de Medicina, Departamento de Microbiología y Parasitología, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Jose L MendezFacultad de Medicina, Departamento de Microbiología y Parasitología, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Luis F Mundo-GallardoGastroenterología, Hospital Angeles del Pedregal, Mexico City, Mexico.
Joaquín Manzo-MerinoCátedras CONACyT-Instituto Nacional de Cancerología, Mexico City, Mexico.
Sergio AyalaCátedras CONACyT-Instituto Nacional de Cancerología, Mexico City, Mexico.ORCID 0000-0001-9746-7560
Alejandro CraviotoFacultad de Medicina, Departamento de Microbiología y Parasitología, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Universidad Nacional Autónoma de México · MXInstituto Nacional de Cancerología · MXHospital Angeles Pedregal · MXHospital General Dr. Manuel Gea Gonzalez · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Helicobacter pylori is a Gram-negative bacterium that causes chronic atrophic gastritis and peptic ulcers and it has been associated with the development of gastric adenocarcinoma and mucosa-associated lymphoid tissue (MALT). One of the more remarkable characteristics of H. pylori is its ability to survive in the hostile environment of the stomach. H. pylori regulates the expression of specific sets of genes allowing it to survive high acidity levels and nutrient scarcity. In the present study, we determined the expression of virulence associated protein D (VapD) of H. pylori inside adenocarcinoma gastric (AGS) cells and in gastric biopsies. Using qRT-PCR, VapD expression was quantified in intracellular H. pylori-AGS cell cultures at different time points and in gastric mucosa biopsies from patients suffering from chronic atrophic gastritis, follicular gastritis, peptic ulcers, gastritis precancerous intestinal metaplasia and adenocarcinoma. Our results show that vapD of H. pylori presented high transcription levels inside AGS cells, which increased up to two-fold above basal values across all assays over time. Inside AGS cells, H. pylori acquired a coccoid form that is metabolically active in expressing VapD as a protection mechanism, thereby maintaining its permanence in a viable non-cultivable state. VapD of H. pylori was expressed in all gastric biopsies, however, higher expression levels (p = 0.029) were observed in gastric antrum biopsies from patients with follicular gastritis. The highest VapD expression levels were found in both antrum and corpus gastric biopsies from older patients (>57 years old). We observed that VapD in H. pylori is a protein that is only produced in response to interactions with eukaryotic cells. Our results suggest that VapD contributes to the persistence of H. pylori inside the gastric epithelial cells, protecting the microorganism from the intracellular environment, reducing its growth rate, enabling long-term infection and treatment resistance.

Indexed as

AdenocarcinomaAdolescentAdultAgedAged, 80 and overBacterial ProteinsBiopsyCoculture TechniquesFemaleGastric MucosaGastritis, AtrophicGastroscopyHelicobacter InfectionsHelicobacter pyloriHumansIntestinesBacterial ProteinsMembrane GlycoproteinsVapD protein, Bacteria

Identifiers

PMID32163505
PMCPMC7067408
OpenAlexW3011497897

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.